Literature DB >> 15784831

Reproductive issues for women with BRCA mutations.

Lois C Friedman1, Rita M Kramer.   

Abstract

Women carrying BRCA1 and BRCA2 mutations face difficult and confusing reproductive decisions that fall into three categories: issues relating to risk-reducing surgeries, issues relating to use of oral contraceptives/tubal ligation, and issues relating to pregnancy and breastfeeding. Risk-reducing surgeries may confer survival benefits, but they also affect quality of life. Oral contraceptives potentially protect mutation carriers against ovarian cancer but increase the risk of early-onset breast cancer, and evidence for the efficacy of tubal ligation in reducing ovarian cancer risk in BRCA mutation carriers is contradictory. Women with BRCA mutations may increase their risk of breast cancer by becoming pregnant before age 40 years, but breastfeeding may decrease risk of breast cancer in women with BRCA mutations, regardless of age. BRCA mutation carriers desiring to become pregnant must deal with a variety of psychosocial issues, some with significant ethical implications, with minimal guidance from research.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784831     DOI: 10.1093/jncimonographs/lgi012

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  11 in total

1.  Pregnancy after Breast Cancer: Myths and Facts.

Authors:  Olivia Pagani; Hatem Azim
Journal:  Breast Care (Basel)       Date:  2012-06-27       Impact factor: 2.860

Review 2.  Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.

Authors:  Sandhya Pruthi; Bobbie S Gostout; Noralane M Lindor
Journal:  Mayo Clin Proc       Date:  2010-12       Impact factor: 7.616

3.  "It was an Emotional Baby": Previvors' Family Planning Decision-Making Styles about Hereditary Breast and Ovarian Cancer Risk.

Authors:  Marleah Dean; Emily A Rauscher
Journal:  J Genet Couns       Date:  2017-01-30       Impact factor: 2.537

4.  "My funky genetics": BRCA1/2 mutation carriers' understanding of genetic inheritance and reproductive merger in the context of new reprogenetic technologies.

Authors:  Allison Werner-Lin; Lisa R Rubin; Maya Doyle; Rikki Stern; Katie Savin; Karen Hurley; Michal Sagi
Journal:  Fam Syst Health       Date:  2012-06       Impact factor: 1.950

5.  Impact of BRCA1/2 mutation on young women's 5-year parenthood rates: a prospective comparative study (GENEPSO-PS cohort).

Authors:  Julien Mancini; Emmanuelle Mouret-Fourme; Catherine Noguès; Claire Julian-Reynier
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

Review 6.  Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.

Authors:  Tuya Pal; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2012-10       Impact factor: 3.302

7.  Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats.

Authors:  Edward W Blank; Po-Yin Wong; Rajkumar Lakshmanaswamy; Raphael Guzman; Satyabrata Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

8.  Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers.

Authors:  Ashley D Staton; Allison W Kurian; Kristin Cobb; Meredith A Mills; James M Ford
Journal:  Fam Cancer       Date:  2007-11-17       Impact factor: 2.375

Review 9.  Genetics: breast cancer as an exemplar.

Authors:  Rebekah Hamilton
Journal:  Nurs Clin North Am       Date:  2009-09       Impact factor: 1.208

10.  Conflict between values and technology: perceptions of preimplantation genetic diagnosis among women at increased risk for hereditary breast and ovarian cancer.

Authors:  Gwendolyn P Quinn; Susan T Vadaparampil; Lindsey M King; Cheryl A Miree; Sue Friedman
Journal:  Fam Cancer       Date:  2009-06-25       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.